Skip to main content

and
  1. Article

    Open Access

    Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer’s disease

    Brain-directed immunotherapy is a promising strategy to target amyloid-β (Aβ) deposits in Alzheimer’s disease (AD). In the present study, we compared the therapeutic efficacy of the Aβ protofibril targeting an...

    Tobias Gustavsson, Nicole G. Metzendorf, Elin Wik in Alzheimer's Research & Therapy (2023)

  2. Article

    Open Access

    Brain pharmacokinetics of mono- and bispecific amyloid-β antibodies in wild-type and Alzheimer’s disease mice measured by high cut-off microdialysis

    Treatment with amyloid-β (Aβ) targeting antibodies is a promising approach to remove Aβ brain pathology in Alzheimer's disease (AD) and possibly even slow down or stop progression of the disease. One of the ma...

    Ulrika Julku, Mengfei **ong, Elin Wik, Sahar Roshanbin in Fluids and Barriers of the CNS (2022)